Explore Outlook Therapeutics, Inc.'s Q4 2024 financial report detailing a net loss, R&D investments, and market challenges. Key insights for investors on equity dilution and future outlook.
Explore Outlook Therapeutics, Inc.'s crucial 8-K report detailing significant corporate events on February 14, 2025. Stay informed about OTLK stock developments and insights.
Discover key insights from Outlook Therapeutics, Inc.'s 8-K report filed on January 16, 2025. Learn about their SEC filing, company details, and securities information.
Explore Outlook Therapeutics, Inc.'s (OTLK) latest financial report revealing significant losses and liquidity concerns. Key insights on R&D, debt, and clinical trial prospects.
Explore the latest 8-K filing by Outlook Therapeutics, Inc. detailing significant events on December 27, 2024. Stay informed on biotech developments impacting OTLK stock.